Antonin Saldmann

582 total citations
9 papers, 409 citations indexed

About

Antonin Saldmann is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Antonin Saldmann has authored 9 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 4 papers in Immunology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Antonin Saldmann's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Antonin Saldmann is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Immunotherapy and Immune Responses (3 papers). Antonin Saldmann collaborates with scholars based in France, Belgium and United States. Antonin Saldmann's co-authors include Éric Tartour, Clémence Granier, Charlotte Blanc, Éléonore De Guillebon, Stéphane Oudard, Hélène Roussel, Alain Gey, Cécile Badoual, Thi Tran and Corinne Tanchot and has published in prestigious journals such as International Journal of Cancer, Gene and Journal of Visualized Experiments.

In The Last Decade

Antonin Saldmann

9 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antonin Saldmann France 6 298 205 92 73 34 9 409
Chakradhar Yakkala Switzerland 8 162 0.5× 292 1.4× 117 1.3× 90 1.2× 41 1.2× 10 517
Lauren M. Eastman United States 4 350 1.2× 251 1.2× 107 1.2× 66 0.9× 14 0.4× 6 434
Joyce M. Lubbers Netherlands 5 295 1.0× 338 1.6× 81 0.9× 36 0.5× 22 0.6× 6 459
Iñaki Eguren‐Santamaría Spain 7 203 0.7× 223 1.1× 83 0.9× 97 1.3× 31 0.9× 17 394
Lillian Sun United States 7 378 1.3× 298 1.5× 120 1.3× 63 0.9× 29 0.9× 9 508
Hans Anton Schloesser Germany 5 247 0.8× 168 0.8× 136 1.5× 89 1.2× 61 1.8× 11 438
Ekaterina Zmievskaya Russia 10 291 1.0× 177 0.9× 166 1.8× 38 0.5× 61 1.8× 18 452
Gesa Schuebbe Germany 3 239 0.8× 163 0.8× 147 1.6× 95 1.3× 65 1.9× 6 445
Alison M. McDonnell Australia 16 432 1.4× 415 2.0× 85 0.9× 130 1.8× 31 0.9× 25 650
Mohamed Aziz United States 9 193 0.6× 122 0.6× 80 0.9× 66 0.9× 36 1.1× 15 356

Countries citing papers authored by Antonin Saldmann

Since Specialization
Citations

This map shows the geographic impact of Antonin Saldmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antonin Saldmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antonin Saldmann more than expected).

Fields of papers citing papers by Antonin Saldmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antonin Saldmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antonin Saldmann. The network helps show where Antonin Saldmann may publish in the future.

Co-authorship network of co-authors of Antonin Saldmann

This figure shows the co-authorship network connecting the top 25 collaborators of Antonin Saldmann. A scholar is included among the top collaborators of Antonin Saldmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antonin Saldmann. Antonin Saldmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Daban, A., Laura Phan, Antonin Saldmann, et al.. (2023). Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs). OncoImmunology. 12(1). 2204754–2204754. 21 indexed citations
2.
Paolini, Léa, Antonin Saldmann, & Éric Tartour. (2021). Lymphocytes T-CD8 et immunothérapie anti-tumorale : rôle et Ciblage thérapeutique. Bulletin de l Académie Nationale de Médecine. 205(4). 354–363. 1 indexed citations
3.
Benhamouda, Nadine, Nicolas Epaillard, Alain Gey, et al.. (2021). P09.05 Plasma CD27, a surrogate of intratumoral CD27-CD70 interaction, correlates with immunotherapy resistance in renal cancer. Poster presentations. A30.1–A30. 2 indexed citations
4.
Guillebon, Éléonore De, Antonin Saldmann, Sylvie Séguier, et al.. (2020). Beyond the concept of cold and hot tumors for the development of novel predictive biomarkers and the rational design of immunotherapy combination. International Journal of Cancer. 147(6). 1509–1518. 47 indexed citations
5.
Saldmann, Antonin, et al.. (2020). Characterization and internalization of nanodiamond–trehalose conjugates into mammalian fibroblast cells of naked mole rat. International nano letters.. 10(2). 151–157. 3 indexed citations
6.
Granier, Clémence, Emeline Vinatier, Marion Mandavit, et al.. (2018). Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1<sup>+</sup> Tim-3<sup>+</sup> CD8<sup>+</sup> T Cells. Journal of Visualized Experiments. 15 indexed citations
7.
Tran, Thi, Charlotte Blanc, Clémence Granier, et al.. (2018). Therapeutic cancer vaccine: building the future from lessons of the past. Seminars in Immunopathology. 41(1). 69–85. 63 indexed citations
8.
Alili, Rohia, Valérie Nivet‐Antoine, Antonin Saldmann, et al.. (2018). Human catalase gene promoter haplotype and cardiometabolic improvement after bariatric surgery. Gene. 656. 17–21. 5 indexed citations
9.
Granier, Clémence, Éléonore De Guillebon, Charlotte Blanc, et al.. (2017). Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer. ESMO Open. 2(2). e000213–e000213. 252 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026